Brazil's medtech, drug companies to comment on government regs

02/20/2013 | Clinica

Anvisa, Brazil's regulatory agency for health care products, is giving the industry an opportunity to comment on its review procedures and regulations for 2013-2014. The consultation process encompasses more than 200 of Brazil's health care groups, including associations for medical device importers, implant manufacturers and dealers, and diagnostic laboratories.

View Full Article in:

Clinica

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI